Enzymatic strategies using hyaluronidase on the EV surface aim to increase EV uptake by degrading the tumor extracellular matrix, improving permeability for both tumor-specific CD8 T cells and drugs in the tumor microenvironment [61]. This evidence concerns the gene CD8A and neoplasm.